Pfizer Posts Solid Quarter

10/16/02 - 08:50 AM EDT

Adam Feuerstein

Pfizer(PFE Quote) reported Tuesday that third-quarter operating profits rose 12%, bolstered by strong drug sales.

The world's largest drug company, which is in the midst of acquiring Pharmacia(PHA Quote), is an exception to what is expected to be a rather dismal earnings season for Big Pharma. Pfizer is the only drug company expected to post double-digit earnings growth in the third quarter.

Looking ahead, Pfizer forecast fourth-quarter and 2002 earnings growth of 38% and 21%, respectively, and said its expects the Pharmacia merger to close by year's end.

New York-based Pfizer said third-quarter reported net income totaled $2.35 billion, or 38 cents per share. These earnings include accounting changes, merger related costs and other items.

Excluding these charges, Pfizer said third-quarter net income was $2.45 billion, or 39 cents per share, compared to net income of $2.18 billion, or 24 cents per share, in the third quarter last year.

Analysts were expecting Pfizer to earn 38 cents a share in the third quarter, according to Thomson Financial/First Call.

Third-quarter revenue grew 12% to $8.73 billion, from $7.82 billion last year. Pfizer's drug sales totaled nearly 7.1 billion, a 13% increase from sales in the year-ago quarter.

Pfizer is buying Pharmacia in part to gain full control over the Celebrex/Bextra arthritis drug franchise. Revenue from the current alliance with Pharmacia rose 15% to $360 million in the third quarter.

Lipitor, the company's cholesterol fighter and top-selling drug, racked up third-quarter sales of $1.35 billion, a 19% increase from the first quarter last year.

First-quarter sales of the impotence drug Viagra rose 15% to $256 million, while sales of the anti-depressant Zoloft rose 7% to $524 million.

In the fourth quarter, Pfizer is forecasting earnings, minus certain charges, of 47 cents per share, a penny shy of current Wall Street expectations. The company also reaffirmed 2002 earnings guidance of $1.58 a share, equal to Wall Street expectations.

< Previous
1 2
Your Recent Quotes: Quote Up0 | Quote Down0
 
Dow S&P 500 NASDAQ
Oil*
64.10
8,324.87
898.72
1,787.40
10 Yr
3.51%
44.13
2.30
9.12
+0.53%
+0.26%
-0.51%
Data delayed 20 min
Get Jim Cramer's Free Newsletter

The Daily Booyah!
Get your daily dose of Cramer in your inbox.
Submit
We respect your privacy.

Premium Stock Ideas
Access Action Alerts Plus to find out Cramer's latest picks now!

Brokerage Partners